SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
远山
Lv3
5
300 积分
2024-08-22 加入
最近求助
最近应助
互助留言
Long-lived autoreactive plasma cells drive persistent autoimmune inflammation
1天前
已完结
Rituximab in Severe Lupus Nephritis
3天前
已完结
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
10天前
已完结
Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results
18天前
已完结
A Novel Anti-CD38 Monoclonal Antibody for Treating Immune Thrombocytopenia
23天前
已完结
Phase 1 Study of Safety and Preliminary Clinical Activity of JNJ-63898081, a PSMA and CD3 Bispecific Antibody, for Metastatic Castration-Resistant Prostate Cancer
25天前
已完结
A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer
25天前
已完结
Advancements and challenges in CAR T cell therapy in autoimmune diseases
1个月前
已完结
Teclistamab-Induced Remission in Refractory Systemic Lupus Erythematosus Teclistamab
1个月前
已关闭
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
1个月前
已完结
没有进行任何应助
我求助文章标题:Teclistamab-Induced Remission in Refractory Systemic Lupus Erythematosus Teclistamab,doi:10.1056/NEJMc2407150,供者文章标题:Achievable but elusive: LLDAS and DORIS remission in clinical trials of belimumab,与求助文章不一致
1个月前
不是我要找的文章
2个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论